| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 136, 207-217, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
C Vogler, EH Birkenmeier, WS Sly, B Levy, C Pegors, JW Kyle and WG Beamer
Department of Pathology and Laboratory Medicine, St. Louis University School of Medicine, Missouri.
This report describes the clinical and pathologic alterations found in mice that have a recessively inherited, essentially complete deficiency of the lysosomal enzyme beta-glucuronidase. Affected animals have a shortened life span and are dysmorphic and dwarfed. Abnormal gait and decreased joint mobility correlate with glycosaminoglycan accumulation in articular tissue and cartilaginous and bony lesions result in extensive skeletal deformation. In these enzyme-deficient animals, lysosomes, distended by fine fibrillar and granular storage material, are particularly prominent in the macrophage system but also occur in other tissues including the skeletal and central nervous systems. The clinical and pathologic abnormalities in these mutant mice closely parallel those identified in humans with mucopolysaccharidoses (MPS). Therefore, these mice provide a well-defined genetic system for the analysis of the pathophysiology of mucopolysaccharidosis type VII, which has many features in common with the other MPS. The mutant mice provide an attractive animal model to test potential therapies for lysosomal storage disease.
This article has been cited by other articles:
 |
|
 |
|
  D. C. Martin, V. Atmuri, R. J. Hemming, J. Farley, J. S. Mort, S. Byers, S. Hombach-Klonisch, R. Stern, and B. L. Triggs-Raine A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis Hum. Mol. Genet., July 1, 2008; 17(13): 1904 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Sly, C. Vogler, J. H. Grubb, B. Levy, N. Galvin, Y. Tan, T. Nishioka, and S. Tomatsu Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors PNAS, October 10, 2006; 103(41): 15172 - 15177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomatsu, M. Gutierrez, T. Nishioka, M. Yamada, M. Yamada, Y. Tosaka, J. H. Grubb, A. M. Montano, M. B. Vieira, G. G. Trandafirescu, et al. Development of MPS IVA mouse (Galnstm(hC79S{middle dot}mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase Hum. Mol. Genet., November 15, 2005; 14(22): 3321 - 3335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, I. Martins, J. A. Wemmie, J. A. Chiorini, and B. L. Davidson Functional Correction of CNS Phenotypes in a Lysosomal Storage Disease Model Using Adeno-Associated Virus Type 4 Vectors J. Neurosci., October 12, 2005; 25(41): 9321 - 9327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. LeBowitz, J. H. Grubb, J. A. Maga, D. H. Schmiel, C. Vogler, and W. S. Sly Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice PNAS, March 2, 2004; 101(9): 3083 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. T. Schuldt, T. J. Hampton, V. Chu, C. A. Vogler, N. Galvin, M. D. Lessard, and J. E. Barker Electrocardiographic and other cardiac anomalies in {beta}-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation PNAS, January 13, 2004; 101(2): 603 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomatsu, K. O. Orii, C. Vogler, J. Nakayama, B. Levy, J. H. Grubb, M. A. Gutierrez, S. Shim, S. Yamaguchi, T. Nishioka, et al. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease Hum. Mol. Genet., December 15, 2003; 12(24): 3349 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Xu, B. Quinn, D. Witte, and G. A. Grabowski Viable Mouse Models of Acid {beta}-Glucosidase Deficiency: The Defect in Gaucher Disease Am. J. Pathol., November 1, 2003; 163(5): 2093 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Passini, D. J. Watson, C. H. Vite, D. J. Landsburg, A. L. Feigenbaum, and J. H. Wolfe Intraventricular Brain Injection of Adeno-Associated Virus Type 1 (AAV1) in Neonatal Mice Results in Complementary Patterns of Neuronal Transduction to AAV2 and Total Long-Term Correction of Storage Lesions in the Brains of {beta}-Glucuronidase-Deficient Mice J. Virol., June 15, 2003; 77(12): 7034 - 7040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomatsu, K. O. Orii, C. Vogler, J. H. Grubb, E. M. Snella, M. Gutierrez, T. Dieter, C. C. Holden, K. Sukegawa, T. Orii, et al. Production of MPS VII mouse (Gustm(hE540A{middle dot}mE536A)Sly) doubly tolerant to human and mouse {beta}-glucuronidase Hum. Mol. Genet., May 1, 2003; 12(9): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Hennig, B. Levy, J. M. Ogilvie, C. A. Vogler, N. Galvin, S. Bassnett, and M. S. Sands Intravitreal Gene Therapy Reduces Lysosomal Storage in Specific Areas of the CNS in Mucopolysaccharidosis VII Mice J. Neurosci., April 15, 2003; 23(8): 3302 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vogler, N. Galvin, B. Levy, J. Grubb, J. Jiang, X. Y. Zhou, and W. S. Sly Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors PNAS, March 4, 2003; 100(5): 2669 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Hofling, C. Vogler, M. H. Creer, and M. S. Sands Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease Blood, March 1, 2003; 101(5): 2054 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomatsu, K. O. Orii, C. Vogler, J. H. Grubb, E. M. Snella, M. A. Gutierrez, T. Dieter, K. Sukegawa, T. Orii, N. Kondo, et al. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis PNAS, November 12, 2002; 99(23): 14982 - 14987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Young, A. A. Hofling, and M. S. Sands VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients PNAS, September 3, 2002; 99(18): 11951 - 11956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Passini, E. B. Lee, G. G. Heuer, and J. H. Wolfe Distribution of a Lysosomal Enzyme in the Adult Brain by Axonal Transport and by Cells of the Rostral Migratory Stream J. Neurosci., August 1, 2002; 22(15): 6437 - 6446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Sands, C. A. Vogler, K. K. Ohlemiller, M. S. Roberts, J. H. Grubb, B. Levy, and W. S. Sly Biodistribution, Kinetics, and Efficacy of Highly Phosphorylated and Non-phosphorylated beta -Glucuronidase in the Murine Model of Mucopolysaccharidosis VII J. Biol. Chem., November 9, 2001; 276(46): 43160 - 43165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Casal and J. H. Wolfe In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of {beta}-glucuronidase can delay onset of clinical signs Blood, March 15, 2001; 97(6): 1625 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Soper, M. D. Lessard, C. A. Vogler, B. Levy, W. G. Beamer, W. S. Sly, and J. E. Barker Nonablative neonatal marrow transplantation attenuates functional and physical defects of {beta}-glucuronidase deficiency Blood, March 1, 2001; 97(5): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohashi, T. Yokoo, S. Iizuka, H. Kobayashi, W. S. Sly, and Y. Eto Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages Blood, June 1, 2000; 95(11): 3631 - 3633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H.Y. Chang, C. A. Bindloss, G. A. Grabowski, X. Qi, B. Winchester, J. J. Hopwood, and P. J. Meikle Saposins A, B, C, and D in Plasma of Patients with Lysosomal Storage Disorders Clin. Chem., February 1, 2000; 46(2): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Freeman, M. S. Roberts, C. A. Vogler, A. Nicholes, A. A. Hofling, and M. S. Sands Behavior and Therapeutic Efficacy of beta -Glucuronidase-Positive Mononuclear Phagocytes in a Murine Model of Mucopolysaccharidosis Type VII Blood, September 15, 1999; 94(6): 2142 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lorincz, L. A. Herzenberg, Z. Diwu, J. A. Barranger, and W. G. Kerr Detection and Isolation of Gene-Corrected Cells in Gaucher Disease Via a Fluorescence-Activated Cell Sorter Assay for Lysosomal Glucocerebrosidase Activity Blood, May 1, 1997; 89(9): 3412 - 3420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohashi, K. Watabe, K. Uehara, W. S. Sly, C. Vogler, and Y. Eto Adenovirus-mediated gene transfer and expression of human beta -glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice PNAS, February 18, 1997; 94(4): 1287 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Sly, C. Vogler, J. H. Grubb, M. Zhou, J. Jiang, X. Y. Zhou, S. Tomatsu, Y. Bi, and E. M. Snella Active site mutant transgene confers tolerance to human beta -glucuronidase without affecting the phenotype of MPS VII mice PNAS, February 27, 2001; 98(5): 2205 - 2210. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
